SymbolHCWB
NameHCW BIOLOGICS INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address2929 N COMMERCE PARKWAY, MIRAMAR, Florida, 33025, United States
Telephone+1 954 842-2024
Fax
Email
Websitehttps://www.hcwbiologics.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001828673
Description

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

Additional info from NASDAQ:
HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

2026-05-14 20:31

(30% Negative) HCW BIOLOGICS INC. (HCWB) Reports Q2 2026 Financial Results

Read more
2026-05-14 20:25

HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results

Read more
2026-05-14 11:30

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

Read more
2026-05-13 17:37

New Form POS AM - HCW Biologics Inc. <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001493152-26-022758 <b>Size:</b> 791 KB

Read more
2026-04-30 20:20

HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

Read more
2026-04-30 07:15

New Form EFFECT - HCW Biologics Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 9999999995-26-001391 <b>Size:</b> 1 KB

Read more
2026-04-28 18:28

New Form ARS - HCW Biologics Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001493152-26-019412 <b>Size:</b> 1 MB

Read more
2026-04-27 11:30

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

Read more
2026-04-24 18:30

New Form S-1/A - HCW Biologics Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001493152-26-018992 <b>Size:</b> 777 KB

Read more
2026-04-23 18:13

New Form S-1 - HCW Biologics Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001493152-26-018758 <b>Size:</b> 1 MB

Read more